Aaron Briggs e Kathryn Restaino

• Allen H.D, Shaddy R.E, Penny D.J, Feltes T.F, Cetta F, eds. Moss and Adams’ Heart Disease in Infants, Children, and Adolescents Including the Fetus and Young Adult . 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2016.
• Feltes T.F, Bacha E, Beekman 3rd. R.H, American Heart Association Congenital Cardiac Defects Committee of the Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; Council on Cardiovascular Radiology and Intervention; American Heart Association, , et al. Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation . 2011;123(22):2607–2652.
• Maron B.J, Zipes D.P, Kovacs R.J, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: preamble, principles, and general considerations: a scientific statement from the American Heart Association and American College of Cardiology. Circulation . 2015;132(22):e256–e261.

Aaron Briggs e David M. Finkelstein

• Atz A.M, Zak V, Mahony L, et al. Longitudinal outcomes of patients with single ventricle after the Fontan procedure. J Am Coll Cardiol . 2017;69(22):2735–2744.
• Gaynor JW, Stopp C, Wypij D, et al. Neurodevelopmental outcomes after cardiac surgery in infancy. Pediatrics. 201;135(5):816-825.
• Glatz A.C, Petit C.J, Goldstein B.H, et al. Comparison between patent ductus arteriosus stent and modified Blalock-Taussig shunt as palliation for infants with ductal-dependent pulmonary blood flow: insights from the Congenital Catheterization Research Collaborative. Circulation . 2018;137(6):589–601.
• Villafañe J, Lantin-Hermoso M.R, Bhatt A.B, et al. D-transposition of the great arteries: the current era of the arterial switch operation. J Am Coll Cardiol . 2014;64(5):498–511.

Sarah Jaffar e Dustin Nash

• Behere S.P, Weindling S.N. Inherited arrhythmias: the cardiac channelopathies. Ann Pediatr Cardiol . 2015;8(3):210–220.
• Chandra N, Bastiaenen R, Papadakis M, Sharma S. Sudden cardiac death in young athletes: practical challenges and diagnostic dilemmas. J Am Coll Cardiol . 2013;61(10):1027–1040.
• Ferdman D.J, Liberman L, Silver E.S. A smartphone application to diagnose the mechanism of pediatric supraventricular tachycardia. Pediatr Cardiol . 2015;36(7):1452–1457.
• Ghosh R.M, Gates G.J, Walsh C.A, Schiller M.S, Pass R.H, Ceresnak S.R. The prevalence of arrhythmias, predictors for arrhythmias, and safety of exercise stress testing in children. Pediatr Cardiol . 2015;36(3):584–590.
• Spearman A.D, Williams P. Supraventricular tachycardia in infancy and childhood. Pediatr Ann . 2014;43(11):456–460.
• Tracy C.M, Epstein A.E, Darbar D, et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Thorac Cardiovasc Surg . 2012;144(6):e127–e145.

Gayathri Prabhakar e Travus White

• Bozkurt B, Colvin M, Cook J, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a Scientific Statement from the American Heart Association. Circulation . 2016;134(23).
• Costanzo M.R, Costanzo M.R, Dipchand A, et al. The International Society of heart and lung transplantation guidelines for the care of heart transplant recipients. J Heart and Lung Transplant . 2010;29(8):914–956.
• Kirk R, Dipchand A.I, Rosenthal D.N, et al. The International Society for heart and lung transplantation guidelines for the management of pediatric heart failure: executive summary. J Heart and Lung Transplant . 2014;33(9):888–909.
• Lipshultz S.E, Law Y.M, Asante-Korang A, et al. Cardiomyopathy in children: classification and diagnosis: a Scientific Statement from the American Heart Association. Circulation . 2019;140(1):e9–e68.
• Maron B.J, Udelson J.E, Bonow R.O, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis. Circulation . 2015;132(22).
• O’Connor M.J, Lorts A, Davies R.R, et al. Early experience with the HeartMate 3 continuous-flow ventricular assist device in pediatric patients and patients with congenital heart disease: a multicenter registry analysis. J Heart and Lung Transplant . 2020;39(6):573–579.
• Sagar S, Liu P.P, Cooper Jr. L.T. Myocarditis. Lancet . 2012;379(9817):738–747.
• VanderPluym C.J, Adachi I, Niebler R, et al. Outcomes of children supported with an intracorporeal continuous-flow left ventricular assist system. J Heart and Lung Transplant . 2019;38(4):385–393.

Sarah Jaffar e Catherine E. Tomasulo

• Ackerman M, Atkins D.L, Triedman J.K. Sudden cardiac death in the young. Circulation . 2016;133(10):1006–1026.
• Chandra N, Bastiaenen R, Papadakis M, Sharma S. Sudden cardiac death in young athletes: practical challenges and diagnostic dilemmas. J Am Coll Cardiol . 2013;61(10):1027–1040.
• Friedman K.G, Alexander M.E. Chest pain and syncope in children: a practical approach to the diagnosis of cardiac disease. J Pediatr . 2013;163(3):896–901 e1-3.
• Harahsheh A.S, O’Byrne M.L, Pastor B, Graham D.A, Fulton D.R. Pediatric chest pain-low-probability referral: a multi-institutional analysis from Standardized Clinical Assessment and Management Plans (SCAMPs®), the pediatric health information systems database, and the National ambulatory medical care survey. Clin Pediatr (Phila). 2017;56(13):1201–1208.
• Koene R.J, Adkisson W.O, Benditt D.G. Syncope and the risk of sudden cardiac death: evaluation, management, and prevention. J Arrhythm . 2017;33(6):533–544.
• Sedaghat-Yazdi F, Koenig P.R. The teenager with palpitations. Pediatr Clin North Am . 2014;61(1):63–79.

Acute Rheumatic Fever and Rheumatic Heart Disease

• Carapetis J.R, Beaton A, Cunningham M.W, et al. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primers . 2016;2:15084.
• Cilliers A, Adler A.J, Saloojee H. Anti-inflammatory treatment for carditis in acute rheumatic fever. Cochrane Database Sys Rev . 2015;5:CD003176.
• Gerber M.A, Baltimore R.S, Eaton C.B, et al. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation . 2009;119(11):1541–1551.
• Gewitz M.H, Baltimore R.S, Tani L.Y, et al. Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation . 2015;131(20):1806–1818.
• McIsaac W.J, Kellner J.D, Aufricht P, et al. Empirical validation of guidelines for the management of pharyngitis in children and adults. J Am Med Assoc . 2004;291(13):1587–1595.
• Nishimura R.A, Otto C.M, Bonow R.O, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation . 2017;135(25):e1159–e1195.

Infective Endocarditis

• Baltimore R.S, Gewitz M, Baddour L.M, et al. Infective endocarditis in childhood: 2015 update. Circulation . 2015;132:1487–1515.
• Habib G, Lancellotti P, Antunes M.J, et al. 2015 ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Eur Heart J . 2015;36(44):3075–3128.
• Li J.S, Sexton D.J, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis . 2000;30(4):633–638.
• Sun L.C, Lai C.C, Wang C.Y, et al. Risk factors for infective endocarditis in children with congenital heart diseases: a nationwide population-based case control study. Int J Cardiol . 2017;248:126–130.
• Wilson W, Taubert K.A, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation . 2007;116(15):1736–1754.

Kawasaki Disease

• McCrindle B.W, Rowley A.H, Newburger J.W, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation . 2017;135(17):e927–e999.